Download MendeleyUnique Sulfur-Aromatic Interactions Contribute to the Binding of Potent Imidazothiazole Indoleamine 2,3-Dioxygenase Inhibitors.
Peng, Y.H., Liao, F.Y., Tseng, C.T., Kuppusamy, R., Li, A.S., Chen, C.H., Fan, Y.S., Wang, S.Y., Wu, M.H., Hsueh, C.C., Chang, J.Y., Lee, L.C., Shih, C., Shia, K.S., Yeh, T.K., Hung, M.S., Kuo, C.C., Song, J.S., Wu, S.Y., Ueng, S.H.(2020) J Med Chem 63: 1642-1659
- PubMed: 31961685
- DOI: https://doi.org/10.1021/acs.jmedchem.9b01549
- Primary Citation of Related Structures:
6KOF, 6KPS, 6KW7 - PubMed Abstract:
Indoleamine 2,3-dioxygenase (IDO1) inhibitors are speculated to be useful in cancer immunotherapy, but a phase III clinical trial of the most advanced IDO1 inhibitor, epacadostat, did not meet its primary end point and was abandoned. In previous work, we identified the novel IDO1 inhibitor N -(4-chlorophenyl)-2-((5-phenylthiazolo[2,3- c ][1,2,4]triazol-3-yl)thio)acetamide 1 through high-throughput screening (HTS). Herein, we report a structure-activity relationship (SAR) study of this compound, which resulted in the potent IDO1 inhibitor 1-(4-cyanophenyl)-3-(3-(cyclopropylethynyl)imidazo[2,1- b ]thiazol-5-yl)thiourea 47 (hIDO IC 50 = 16.4 nM). X-ray cocrystal structural analysis revealed that the basis for this high potency is a unique sulfur-aromatic interaction network formed by the thiourea moiety of 47 with F163 and F226. This finding is expected to inspire new approaches toward the discovery of potent IDO1 inhibitors in the future.
Organizational Affiliation:
Institute of Biotechnology and Pharmaceutical Research , National Health Research Institutes , Miaoli County 35053 , Taiwan.
